Discontinued — last reported Q4 '25
Other
Debt securities, available-for-sale, unrealized gain
Insmed Debt securities, available-for-sale, unrealized gain remained flat by 0.0% to $100.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $75.00K to $100.00K. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ4 2025Feb 19, 2026
How to read this metric
Reflects the performance of the company's treasury or investment portfolio in response to market interest rate changes.
Detailed definition
The gross unrealized gains on debt securities classified as available-for-sale, representing the difference between the...
Peer comparison
Standard for companies with significant cash reserves invested in marketable securities.
Metric ID:
other_available_for_sale_debt_securities_gross_unrealized_gainHistorical Data
2 years
| FY'24 | FY'25 | |
|---|---|---|
| Value | $300.00K | $400.00K |
| YoY Change | — | +33.3% |
Range$300.00K – $400.00K
Avg YoY Growth+33.3%
Median YoY Growth+33.3%
Debt securities, available-for-sale, unrealized gain at Other Companies
Frequently Asked Questions
- What is Insmed's debt securities, available-for-sale, unrealized gain?
- Insmed (INSM) reported debt securities, available-for-sale, unrealized gain of $100.00K in Q4 2025.
- How has Insmed's debt securities, available-for-sale, unrealized gain changed year-over-year?
- Insmed's debt securities, available-for-sale, unrealized gain increased by 33.3% year-over-year, from $75.00K to $100.00K.
- What does debt securities, available-for-sale, unrealized gain mean?
- The paper profit on debt investments that the company holds but has not yet sold.